Multilocus genetic profiling to empower drug trials and predict brain atrophy.

Neuroimage Clin · 2013 · PMC3777716 · PMID 24179834

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

fell short of significancep ~ 0.11not close (p > 0.1)

Selecting the top ~ 10% of control subjects with highest genetic risk reduces this further to 55, but this reduction still fell short of significance when compared to permutations ( p ~ 0.11).

also in 361 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.